Advertisement
Advertisement
U.S. markets open in 6 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

MariMed Inc. (MRMD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4600+0.0049 (+1.08%)
At close: 03:54PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.4551
Open0.4600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4500 - 0.5100
52 Week Range0.4000 - 1.1400
Volume263,746
Avg. Volume441,658
Market Cap154.465M
Beta (5Y Monthly)3.23
PE Ratio (TTM)23.00
EPS (TTM)0.0200
Earnings DateAug 15, 2022 - Aug 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MRMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MARIMED INC
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • GlobeNewswire

    MariMed Receives Media Awards For “World’s Largest Cannabis Brownie” PR Campaign

    NORWOOD, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced its recent “World’s Largest Cannabis Brownie” public relations campaign has earned two of the most prestigious national communications awards for its effectiveness in driving visibility of the Company and its Bubby’s Baked infused baked goods product line. MariMed’s craft confectioners baked an 850-pound brownie infused with 20,000 mg

  • GlobeNewswire

    MariMed Awarded Dispensary License in Ohio

    NORWOOD, Mass., May 18, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, announced today it had been awarded a provisional dispensary license (“PDL”) by the Ohio Board of Pharmacy. MariMed won this license in the Ohio lottery process. The license allows the Company to develop a medical dispensary in Tiffin, Ohio, located south of Toledo and home to the University of Bucharest and Tiffin

  • GlobeNewswire

    MariMed Strengthens Executive Leadership Team To Support Accelerated Long-Term Growth

    Jon Levine Elevated to Chief Administration OfficerSusan Villare Appointed Chief Financial Officer NORWOOD, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Administration Officer (“CAO”) and the appointment of Susan Villare to Chief Financial Officer (“CFO”) effective May 12, 2022. Strengthening MariM

Advertisement
Advertisement